Earlier this month, I traveled to Montenegro for a gathering of longevity enthusiasts, people interested in extending human life through various biotechnology approaches. All the attendees were super friendly, and the sense of optimism was palpable. They’re all confident we’ll be able to find a way to slow or reverse aging—and they have a bold plan to speed up progress.
Around 780 of these people have created a “pop-up city” that hopes to circumvent the traditional process of clinical trials. They want to create an independent state where like-minded innovators can work together in an all-new jurisdiction that gives them free rein to self-experiment with unproven drugs. Welcome to Zuzalu. Read the full story.
China isn’t waiting to set down rules on generative AI
Back in April, the Chinese internet regulator published a draft regulation on generative AI. The document doesn’t call out any specific company, but the way it is worded makes it clear that it was inspired by the incessant launch of large-language-model chatbots in China and the US.
The draft regulation is a mixture of sensible restrictions on AI risks and a continuation of China’s strong government tradition of aggressive intervention in the tech industry. But while many of the clauses in the draft regulation are principles that AI critics are advocating for in the West, it also contains rules that other countries would likely balk at. Read the full story.